Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
34.5M
-
Shares change
-
-1.57M
-
Total reported value, excl. options
-
$55.9M
-
Value change
-
-$2.97M
-
Put/Call ratio
-
0.02
-
Number of buys
-
37
-
Number of sells
-
-43
-
Price
-
$1.62
Significant Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q4 2022
108 filings reported holding KRON - Kronos Bio, Inc. - Common Stock as of Q4 2022.
Kronos Bio, Inc. - Common Stock (KRON) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.5M shares
.
Largest 10 shareholders include Omega Fund Management, LLC (3.82M shares), BlackRock Inc. (3.21M shares), Vida Ventures Advisors, LLC (2.77M shares), JPMORGAN CHASE & CO (2.57M shares), PERCEPTIVE ADVISORS LLC (1.75M shares), Artal Group S.A. (1.54M shares), VANGUARD GROUP INC (1.5M shares), Nextech Invest Ltd. (1.45M shares), Wildcat Capital Management, LLC (1.44M shares), and Alphabet Inc. (1.44M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.